Stock Market Today: Dow Jones, S&P 500 Futures Slip As Investors Brace For Mega-Cap Earnings—Brand Engagement, Nucor In Focus

U.S. stock futures dropped on Monday following Friday’s mixed close. Futures of major benchmark indices were lower.

This week, investors are eyeing earnings from UnitedHealth Group Inc. (NYSE:UNH), General Motors Co. (NYSE:GM), Microsoft Corp. (NASDAQ:MSFT), Meta Platforms Inc. (NASDAQ:META), Tesla Inc. (NASDAQ:TSLA), Starbucks Corp. (NASDAQ:SBUX), and others.

The investors will also keep an eye on the Federal Open Market Committee’s decision on interest rates, slated to be announced on Wednesday.

Meanwhile, the 10-year Treasury bond yielded 4.21%, and the two-year bond was at 3.59%. The CME Group's FedWatch tool‘s projections show markets pricing a 97.2% likelihood of the Federal Reserve leaving the current interest rates unchanged in January.

Index

Performance (+/-)

Dow Jones

-0.12%

S&P 500

-0.24%

Nasdaq 100

-0.44%

Russell 2000

-0.29%

The SPDR S&P 500 ETF Trust (NYSE:SPY) and Invesco QQQ Trust ETF (NASDAQ:QQQ), which track the S&P 500 index and Nasdaq 100 index, respectively, were lower in premarket on Monday. The SPY was down 0.22% at $687.69, while the QQQ declined 0.43% to $620.04.

Stocks In Focus

Baker Hughes

Baker Hughes Co. (NASDAQ:BKR) was 3.74% higher in premarket on Monday after posting upbeat results for the fourth quarter. The company posted adjusted earnings of 78 cents per share, beating market estimates of 67 cents per share.

BKR maintains a stronger price trend over the short, medium, and long terms with a moderate value ranking, as per Benzinga's Edge Stock Rankings.

Sarepta Therapeutics

Sarepta Therapeutics Inc. (NASDAQ:SRPT) jumped 6.72% after it announced the completion of the confirmatory trial commitment for its ultra-rare disease PMO therapies AMONDYS 45 and VYONDYS 53, along with its third-quarter results.

Benzinga's Edge Stock Rankings indicate that SRPT maintains a weak price trend over the long term but a strong trend in the short and medium terms.